Cargando…
Effect of rapamycin on lysosomal accumulation in a CRISPR/Cas9‐based cellular model of VPS13A deficiency
VPS13A is a lipid transfer protein localized at different membrane contact sites between organelles, and mutations in the corresponding gene produce a rare neurodegenerative disease called chorea‐acanthocytosis (ChAc). Previous studies showed that VPS13A depletion in HeLa cells results in an accumul...
Autores principales: | Tornero‐Écija, A. R., Navas, M. A., Muñoz‐Braceras, S., Vincent, O., Escalante, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243151/ https://www.ncbi.nlm.nih.gov/pubmed/37163371 http://dx.doi.org/10.1111/jcmm.17768 |
Ejemplares similares
-
VPS13A is closely associated with mitochondria and is required for efficient lysosomal degradation
por: Muñoz-Braceras, Sandra, et al.
Publicado: (2019) -
The association of lipid transfer protein VPS13A with endosomes is mediated by sorting nexin SNX5
por: Tornero-Écija, Alba, et al.
Publicado: (2023) -
In situ architecture of the lipid transport protein VPS13C at ER–lysosome membrane contacts
por: Cai, Shujun, et al.
Publicado: (2022) -
Recruitment of VPS33A to HOPS by VPS16 Is Required for Lysosome Fusion with Endosomes and Autophagosomes
por: Wartosch, Lena, et al.
Publicado: (2015) -
VPS13A and VPS13C Influence Lipid Droplet Abundance
por: Chen, Shuliang, et al.
Publicado: (2022)